Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Applied StemCell Closes $19 Million Series D for Gene Editing Pipeline

publication date: Jun 6, 2016
Applied StemCell, a Bay-area gene-editing company, raised $19 million in a Series D funding from China investors. The company said it would use the funds to develop its pipeline of therapeutics for monogenic blood disorders and advance its CRISPR and Cas9 gene editing platform. Applied StemCell provides genetically modified human cell lines and transgenic animal models to researchers and also uses its gene editing technology to develop gene/stem cell-based gene therapies. The funding was led by HerMed Capital, a healthcare PE fund formed by Fosun Pharma and the SK Group, a Korean conglomerate. Additional investors included Ping An Ventures, Vi-Ventures and BioSciKin. More details....

Stock Symbols: (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital